Abstract
Pulmonary alveolar proteinosis (PAP) is a disease of unknown etiopathogenesis sometimes associated with malignant haematological disorders. The potential reversibility of the process in these cases seems to be related to recovery from the underlying disease. GM-CSF has acquired an important, potentially pathogenic role and BMT presents one therapeutic option effective in certain forms of human PAP. We present the case of a 43-year-old female patient with Ph+ CML. During pretransplantation evaluation, unexpected pulmonary infiltrates were noted in the chest X-ray, PAP being diagnosed on biopsy. In view of the progressive respiratory symptomatology and her CML being in accelerated phase, the patient underwent haematopoietic transplantation. She died on day +12 from invasive pulmonary aspergillosis before a response could be observed. Pathogenic implications in PAP and the role of haematopoietic transplantation in this disease are discussed.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rguez-Luaces, M., Lafuente, A., Martín, M. et al. Haematopoietic transplantation in pulmonary alveolar proteinosis associated with chronic myelogenous leukaemia. Bone Marrow Transplant 20, 507–510 (1997). https://doi.org/10.1038/sj.bmt.1700915
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1700915
- Springer Nature Limited
Keywords
This article is cited by
-
Pulmonary alveolar proteinosis following allogeneic hematopoietic cell transplantation
Bone Marrow Transplantation (2011)
-
Successful allogeneic bone marrow transplantation for myelodysplastic syndrome complicated by severe pulmonary alveolar proteinosis
International Journal of Hematology (2009)
-
High titer autoantibodies to GM-CSF in patients with AML, CML and MDS are associated with active disease
Leukemia (2008)